Clinical relevance of antikeratin antibodies in rheumatoid arthritis. 1982

P Miossec, and P Youinou, and P Le Goff, and M P Moineau

Antikeratin antibodies (AKA) were found in 38 out of 96 patients with rheumatoid arthritis (RA); they appeared to be quite characteristic to this disease. There was a very low incidence of AKA positivity in the control groups, i.e., 1 out of 62 healthy subjects and 4 out of 158 other patients. With regard to the sensitivity of the test as a diagnostic tool, AKA was found to be weaker than the rheumatoid factor (RF) and the antiperinuclear factor (APF), whereas the specificity was much better than APF and RF. A clear correlation was shown between the titres of AKA and APF (p less than 0.001) and also between AKA levels and inflammation (p less than 0.02).

UI MeSH Term Description Entries
D007633 Keratins A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION. Cytokeratin,Keratin Associated Protein,Keratin,Keratin-Associated Proteins,alpha-Keratin,Associated Protein, Keratin,Keratin Associated Proteins,Protein, Keratin Associated,alpha Keratin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid

Related Publications

P Miossec, and P Youinou, and P Le Goff, and M P Moineau
May 1991, Ugeskrift for laeger,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
January 1987, Scandinavian journal of rheumatology,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
February 1985, The Journal of rheumatology,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
January 2008, Annales de biologie clinique,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
January 2004, Romanian journal of internal medicine = Revue roumaine de medecine interne,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
August 1992, Arthritis and rheumatism,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
May 1995, Zhonghua nei ke za zhi,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
October 1984, The Journal of rheumatology,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
February 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
P Miossec, and P Youinou, and P Le Goff, and M P Moineau
June 1981, Annals of the rheumatic diseases,
Copied contents to your clipboard!